Insights
Search Results
Client Highlights
6.03.26
Wilson Sonsini Advises Isomorphic Labs on $2.1 Billion Series B Investment Round
On May 12, 2026, Isomorphic Labs, an AI-first drug design and development company, announced it has raised $2.1 billion in Series B funding. The financing round is led by Thrive Capital, and includes participation from existing backers Alphabet and GV alongside new investors MGX, Temasek, CapitalG, and the UK Sovereign AI Fund, significantly expanding Isomorphic Labs’ global capital base. Wilson Sonsini Goodrich & Rosati advised Isomorphic Labs on the transaction.
Client Highlights
1.26.26
Wilson Sonsini Advises Sage Geosystems on $97 Million Series B and Strategic Agreement with Ormat
On January 21, 2026, Sage Geosystems, the company pioneering Pressure Geothermal, closed over $97 million in Series B funding to advance its geothermal power generation and energy storage solutions, including its first commercial next-generation geothermal power generation facility. Ormat Technologies and Carbon Direct Capital co-led Sage’s Series B round, representing the full backing of Sage and Pressure Geothermal technology from leaders in geothermal energy and growth capital.
Client Highlights
9.30.25
Firm Advises Novo Holdings and SR One on Crystalys Therapeutics’ $205 Million Series A
On September 30, 2025, Crystalys Therapeutics Inc., a clinical-stage biopharmaceutical company, announced its launch with a $205 million Series A financing to support its mission of addressing the significant unmet medical needs of people living with gout. The financing was co-led by Novo Holdings, SR One, and Catalys Pacific, with participation from a broad syndicate of investors, including Perceptive Xontogeny Venture Funds, Lightstone Ventures, AN Venture Partners, funds managed by abrdn Inc., KB Investments, Pontifax, Longwood Fund, Alexandria Venture Investments, Wedbush Healthcare Partners, and Prebys Ventures Fund. Wilson Sonsini Goodrich & Rosati advised co-lead investors Novo Holdings and SR One on the transaction.
Client Highlights
9.25.25
Wilson Sonsini Advises LALO Tequila on Acquisition by Tito’s
On September 23, 2025, Tito's Handmade Vodka, the brand behind Texas' first legal distillery and the award-winning vodka, announced it has entered into a definitive agreement to acquire the majority stake in LALO Tequila, one of the fastest-growing tequila brands in the United States. Wilson Sonsini Goodrich & Rosati advised LALO on the transaction.
Client Highlights
3.11.24
Wilson Sonsini Advises Bakkt on Concurrent Registered Direct Offerings
On February 29, 2024, Bakkt Holdings, Inc. (Bakkt), a leading crypto services platform, announced its entry into two securities purchase agreements relating to the purchase and sale of up to 57,670,127 shares of the company’s Class A common stock (or pre-funded warrants in lieu of Class A common stock) and accompanying warrants to purchase up to an equal number of shares of the company’s Class A common stock in concurrent registered direct offerings. The purchase price of each share of Class A common stock and accompanying warrant is $0.8670, resulting in aggregate expected gross proceeds of $50 million. Bakkt issued approximately $42.4 million of such securities on March 4, 2024, and will close on the issuance of the incremental approximately $7.6 million of such securities after the company obtains stockholder approval, subject to the satisfaction of other customary closing conditions. Wilson Sonsini Goodrich & Rosati advised Bakkt on the transaction.
Client Highlights
2.07.24
Firm Advises Fannin Partners on Procyrion’s $57.7 Million Series E Financing
On February 5, 2024, Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced the completion of a $57.7 million Series E funding round. The round was led by Fannin Partners in partnership with new and existing family/multi-family office investors. The Series E financing also included participation from returning investors including Bluebird Ventures and an undisclosed strategic investor. Wilson Sonsini Goodrich & Rosati advised lead investor Fannin Partners on the transaction.
Client Highlights
11.03.23
Wilson Sonsini Advises BibliU on Acquisition of Texas Book Company
On October 24, 2023, edtech innovator BibliU announced the acquisition of Texas Book Company, a privately held company in Texas and an industry leader in delivering affordable learning materials to higher education institutions across the U.S. Wilson Sonsini Goodrich & Rosati advised BibliU on the transaction.
Client Highlights
11.04.22
Firm Advises Bakkt on Acquisition of Apex Crypto
On November 3, 2022, digital asset platform Bakkt Holdings Inc. announced the acquisition of Apex Crypto LLC from Apex Fintech Solutions Inc. in a move that will bolster Bakkt’s cryptocurrency product offering and expand its footprint into new client verticals. Wilson Sonsini Goodrich & Rosati advised Bakkt on the deal.